These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26994504)

  • 21. Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database.
    Pinto DS; Kohli P; Fan W; Kirtane AJ; Kociol RD; Meduri C; Deliargyris EN; Prats J; Reynolds MR; Stone GW; Michael Gibson C
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):363-73. PubMed ID: 26011467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age.
    Ndrepepa G; Neumann FJ; Schulz S; Fusaro M; Cassese S; Byrne RA; Richardt G; Laugwitz KL; Kastrati A
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):182-9. PubMed ID: 24030753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry.
    Washam JB; Kaltenbach LA; Wojdyla DM; Patel MR; Klein AJ; Abbott JD; Rao SV
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005628. PubMed ID: 29432119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
    Shelton R; Eftychiou C; Somers K; Liu A; Burton-Wood N; Anderson M; Makri L; Blaxill J; McLenachan J; Wheatcroft S; Greenwood J; Blackman D
    EuroIntervention; 2013 May; 9(1):118-24. PubMed ID: 23410540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
    Liang Z; Li Y; Wang J; Wang D; Wang S; Ma L; Liu H; Yang L; Stone GW; Han Y
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():608-15. PubMed ID: 26762481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
    J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.
    MacHaalany J; Abdelaal E; Bataille Y; Plourde G; Duranleau-Gagnon P; Larose É; Déry JP; Barbeau G; Rinfret S; Rodés-Cabau J; De Larochellière R; Roy L; Costerousse O; Bertrand OF
    Am J Cardiol; 2012 Dec; 110(12):1742-8. PubMed ID: 22980964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
    Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F
    BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.
    Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciardelli B
    JACC Cardiovasc Interv; 2015 Mar; 8(3):414-423. PubMed ID: 25703878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent predictors of bleeding complications in patients undergoing PCI with concomitant treatment with bivalirudin in clinical practice results from the ImproveR registry.
    Koeth O; Gulba D; Huber K; Madsen JK; Darius H; Schneider S; Zeymer U;
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):507-11. PubMed ID: 24072173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.
    Ndrepepa G; Groha P; Lahmann AL; Lohaus R; Cassese S; Schulz-Schüpke S; Kufner S; Mayer K; Bernlochner I; Byrne RA; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):184-90. PubMed ID: 26526702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalirudin use and one-month outcome in the context of contemporary antiplatelet treatment: insights from the Greek Antiplatelet Registry.
    Alexopoulos D; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Karayannis G; Angelidis C; Stavrou K; Vavuranakis M; Goudevenos JA; Stefanadis C;
    Cardiovasc Ther; 2014 Jun; 32(3):120-6. PubMed ID: 24512682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors.
    Abtahian F; Waldo S; Jang IK
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):390-6. PubMed ID: 25753749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.
    Graham JJ; Yan AT; Tan MK; Cantor WJ; DiMario C; Jolly SS; Halvorsen S; Fernandez-Aviles F; Le May MR; Scheller B; Borgia F; Piscione F; Madan M; Goodman SG
    Cardiovasc Revasc Med; 2016; 17(5):295-301. PubMed ID: 27116940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients.
    Rao SV; Dai D; Subherwal S; Weintraub WS; Brindis RS; Messenger JC; Lopes RD; Peterson ED
    JACC Cardiovasc Interv; 2012 Sep; 5(9):958-65. PubMed ID: 22995883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Perdoncin E; Seth M; Dixon S; Cannon L; Khandelwal A; Riba A; David S; Wohns D; Gurm H
    Eur Heart J; 2016 Jun; 37(24):1902-9. PubMed ID: 26377400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry.
    Lopes RD; Peterson ED; Chen AY; Roe MT; Wang TY; Ohman EM; Magid DJ; Ho PM; Wiviott SD; Scirica BM; Alexander KP
    JACC Cardiovasc Interv; 2010 Jun; 3(6):669-77. PubMed ID: 20630461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry.
    Daugherty SL; Thompson LE; Kim S; Rao SV; Subherwal S; Tsai TT; Messenger JC; Masoudi FA
    J Am Coll Cardiol; 2013 May; 61(20):2070-8. PubMed ID: 23524046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
    Ortiz D; Singh M; Jahangir A; Allaqaband S; Khitha J; Bajwa TK; Mewissen MW
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):408-413. PubMed ID: 27526661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.